Clinical Trials Directory

Trials / Sponsors / Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9
Cutaneous Venous Malformations
Phase 22024-12-20
Active Not RecruitingSELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphati
Microcystic Lymphatic Malformation
Phase 32024-07-31
RecruitingA Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of
Pachyonychia Congenita
Phase 32022-11-15
CompletedStudy Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphat
Microcystic Lymphatic Malformation
Phase 22022-01-13
CompletedA Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy o
Pachyonychia Congenita
Phase 32021-11-29
CompletedCODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Ba
BCCs in Gorlin Syndrome Patients
Phase 22021-05-06
CompletedVALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congen
Pachyonychia Congenita
Phase 32020-09-01
CompletedPhase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congeni
Pachyonychia Congenita
Phase 2 / Phase 32019-04-01